Related Experiment Video

Updated: Jul 11, 2026

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Gene therapy approach in prostate cancer cells using an active Wnt signal

Nis Giladi1, Hadas Dvory-Sobol, Eyal Sagiv

  • 1The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Medical Center, 6 Weizmann Street, Tel Aviv 64239, Israel.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|October 2, 2007
PubMed
Abstract

Insights

A novel gene-targeting therapy using Ad-TOP-PUMA adenovirus selectively killed prostate cancer cells with activated beta-catenin/T-cell factor (Tcf) signaling. This approach shows promise for treating prostate cancer by targeting specific molecular pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Beta-catenin/T-cell factor (Tcf) signaling is crucial in early carcinogenesis.
  • The Wnt pathway significantly contributes to prostate cancer development and progression.

Purpose of the Study:

  • To develop a gene-targeting strategy to selectively eliminate human prostate cancer cells exhibiting activated beta-catenin/Tcf signaling.

Main Methods:

  • Utilized a recombinant adenovirus (Ad-TOP-PUMA) with a PUMA lethal gene under a Tcf-responsive promoter.
  • Tested Ad-TOP-PUMA on prostate cancer cells (PC-3) with activated signaling versus inactive signaling (DU145).
  • Assessed cell viability via methylene blue assay and Tcf activity via luciferase assay.

Main Results:

  • Ad-TOP-PUMA demonstrated dose- and time-dependent inhibition of PC-3 cell growth.
  • No significant effect on DU145 cell growth was observed, indicating pathway-specific targeting.

Conclusions:

  • Selective targeting of prostate cancer cells with activated beta-catenin pathways represents a potential novel therapeutic strategy.
  • This gene-targeting approach offers a promising avenue for prostate cancer treatment.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...